Back to Results
First PageMeta Content
Health / Tuberculosis treatment / Extensively drug-resistant tuberculosis / TB Alliance / Moxifloxacin / Pyrazinamide / RNTCP / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Biology


Speeding Development of Shorter, Simpler, Safer, and Affordable TB Treatments Cherise Scott Director, Pediatric Programs
Add to Reading List

Document Date: 2015-04-07 12:37:11

Open Document

File Size: 323,50 KB

Share Result on Facebook

City

Pretoria / Brussels / New York / /

Company

Altana AG / /

Country

United States / South Africa / Belgium / /

/

Event

FDA Phase / /

IndustryTerm

health systems / /

MedicalCondition

TB / XDR-TB / /

Organization

TB Alliance / /

Person

Cherise Scott / /

Position

Director / Pediatric Programs cherise.scott@tballiance.org March / /

Product

NiX / Pyrazinamide / Pa-824 / /

SocialTag